Organic Natural Cosmetics

(PRWEB) June 02, 2015

Pollogen Ltd. will showcase its latest technologies in their booth (1427) at the World Congress of Dermatology (WCD) in Vancouver, Canada June 9-12. Pollogen proven technologies have set new standards for optimal facial and body contouring, dermal volumizing, wrinkle, scar and cellulite reduction. These new technologies are now found in Pollogen’s latest medical aesthetic devices the Pollogen LEGEND with VoluDerm and the geneO+ with OxyGeneo. Pollogen technologies provide treatments that are non-surgical, results that are immediate and long term, with no discomfort and no downtime.

VoluDerm facial rejuvenation treatment – An optimal combination of fine micro-needles and radio frequency for dermal volumizing, wrinkle reduction, and facial skin contouring with no pain or downtime. A recent study published by Dr. Steven D. Shapiro concluded that VoluDerm treatments demonstrated “significant dermal volume enhancement, reduction of wrinkles including nasolabial folds, perioral and periorbital lines. Improvement of neck skin laxity and skin texture, were manifested by radiant skin, smaller pores and general volume increase”.

OxyGeneo– A new facial technology providing a 3-in-1 Super Facial treatment: exfoliation, infusion, and oxygenation. The OxyGeneo treatment is now offered at select Four Season spas.

Pollogen technologies are clinically proven with over 16 articles in peer reviewed journals and is available in 60+ countries and their technologies are cleared by FDA, CE and Canadian MOH. The Company’s premier brands and technologies include: TriPollar®, OxyGeneo®, Hybrid Energy™, VoluDerm™, TriLipo and TriFractional™

The WCD is the world’s oldest continuous international dermatology meeting where the international community of dermatologists meets to discuss breakthrough technologies that are changing the face of beauty in cosmetics and aesthetic medicine, latest findings and leading industry leaders display the most advanced technologies and products.

Pollogen’s CEO, Mr. Amichai Bar-Nir stated: “Pollogen is proud to present its innovative VoluDerm treatment in the 2015 WCD. VoluDerm combines the best aspects of micro-needling and radio frequency in one treatment providing visible results and younger-looking skin. Same as our other Pollogen treatments, it can be done in simple ‘walk in – walk out’ procedures.

About Pollogen

We believe in constantly challenging ourselves to create the most advanced, effective medical aesthetic technologies and solutions.

We believe in thinking differently.

In everything we do, we take a customer-centric approach by making our products user-friendly, safe and convenient. We believe in finding ways to develop technologies that work with the body’s natural mechanisms so beautiful results are generated from within.

Pollogen is the developer and manufacturer of five revolutionary technologies under the industry premier brand names OxyGeneo®, VoluDerm™, Hybrid Energy™, TriPollar®, TriLipo® and TriFractional™. We offer a full line of clinically-proven, safe and effective, non-invasive anti-aging facial and body contouring treatment platforms for a wide range of aesthetic applications. Pollogen provides solutions for professionals in over 60 countries, addressing the specific needs and dynamic changes unique to the ever-evolving aesthetic industry

Related Natural Cosmetics Press Releases

Fremont, CA (PRWEB) April 02, 2015

Lutronic, a leading innovator of aesthetic and medical technology, announced today that it expands its portfolio of innovative medical solutions in Europe with ACTION II Petit Lady ™ at the 13th Anti-Aging Medicine World Congress (AMWC) in Monte-Carlo, Monaco, from March 26-28, 2015. ACTION II is a device that provides a new dimension in Er:YAG laser technology applied for both gynecological and aesthetic indications. It received CE mark clearance for treatment of vaginal relaxation syndrome (VRS) and stress urinary incontinence (SUI) in June 2014, which expands its clinical applications and builds on the success of the original ACTION II device which primarily focused on aesthetic treatments.

“I have seen that ACTION II Petit Lady increases the elasticity of the vaginal wall with a significantly short downtime. Patients suffering from vaginal relaxation syndrome are very satisfied with Petit Lady because this 15-minute non-surgical treatment successfully rejuvenates the vagina and enhances sexual gratification,” said Dr Fabio Marini, a surgeon at the Skin Laser Clinic, in Italy. Dr Marini was presenting on the Petit Lady system at a special dinner Symposium during the AMWC, ‘Symposia L’, hosted by Lutronic. Dr Marini also presented his one year clinical study on ACTION II Petit Lady for vaginal atrophy and vaginal relaxation syndrome, which showed significant improvements in both sets of patients.

The well-attended symposium, which was moderated by Dr R Glen Calderhead, VP Medicoscientific Affairs for Lutronic, also featured Dr. Matteo Tretti Clementoni, a plastic surgeon at Skin House in Italy Dr Clementoni, a world-renowned physician, shared his knowledge of the INFINI™ for treating neck and low face laxity with its High Intensity Focused RF. “The device is very easy to use, and it is possible to perform full face and neck treatment in less than 15 minutes. With varying energy, pulse duration, depth of needles penetration and number of passages, it is possible to customize the treatment for the specific skin needs of each patient on an individual basis. Finally, we have a device/treatment that really allows us to obtain good results on the lower 1/3 of the face and the neck,” he added. Another presenter of INFINI, Dr Harryono Judodihardjo, a dermatologist from the Cellite Clinic, UK also shared his clinical experiences with the title, ‘How to Smooth Out Accordion Lines (Smile Lines).’

Another star speaker was Dr Christine Dierickx, a world-wide respected dermatologist from Skinperium, Belgium, who presented on the Q-switched Nd:YAG-based multiplatform, SPECTRA XT™, which is the latest edition of the cutting-edge SPECTRA family of lasers, already best-known and appreciated for its versatility and reliability.

The symposium was a great success, judging from the many favorable comments from the attendees who were most impressed by the practical and solid nature of the presentations and the range of topics covered by the well-appreciated presenters. This symposium built on the success of the similar event at last year’s AMWC, and many of those present stated that they would definitely be looking to attend again next year, hoping that it will become a tradition to be established by Lutronic at subsequent AMWC meetings.

About ACTION II Petit Lady

The Lutronic ACTION Petit Lady is a 360° solution for cosmetic gynecology. The treatment is gentle, simple and fast. The ACTION II Petit Lady 360° handpiece is specially designed for VRS. It delivers multiple micropulses to the vaginal mucosa to stimulate collagen remodeling and tighten the vaginal canal. The ACTION II Petit Lady 90º handpiece is intended for SUI, providing an enhanced thermal and shrinkage effect in the endopelvic fascia, ligaments, and mucosal tissue of the anterior vaginal canal.

To learn more about the ACTION II Petit Lady, please visit: http://www.petitlady.net/

About LUTRONIC

Lutronic, a leading innovator in advanced aesthetic and medical laser and related technology, was established over 18 years ago to bring intuitive, robust, versatile devices that are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure the efficacy of its systems. All systems are versatile and offer multiple setting and treatment options for customized treatments, which optimize outcomes for a wide variety of conditions and treatments including melasma, tattoo removal, soft tissue incision, vascular lesions, hair removal, wrinkle reduction, skin resurfacing, body/facial contouring, chronic pain and more.

With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 20% of revenues to R&D, Lutronic holds more than 240 intellectual properties including current and pending patents worldwide. With more than 250 employees worldwide, Lutronic has offices in the US, Korea, China, Japan, and Europe, a worldwide network of distributors, and is ever expanding.

For more information about Lutronic and its products, please visit: http://www.lutronic.com

MIAMI (PRWEB) March 17, 2015

GlobalStemCellsGroup.com has announced plans to participate in the 25th annual Argentine Congress of Aesthetic Medicine April 9 and 10 2015. More than 1,000 physicians from around the world will descend on Buenos Aires for the conference to learn and share new findings in aesthetic medicine.

Following the congress, Global Stem Cells Group and Estanislao Janowski, M.D., a plastic surgeon specializing in stem cell application in aesthetic and cosmetic medicine will conduct an intensive, hands-on course on stem cell harvesting, isolation and re-integration, to be held April 11. Janowski, a GSCG faculty member and long-time collaborator is the owner and president of Bioplastica, an aesthetic surgical center featuring the latest stem cell applications in cosmetic and anti-aging medicine.

This will be the third year Global Stem Cells Group participates in the conference, hosted by the Argentina Society of Aesthetic Medicine (SOARME). A soon-to-be-named GSCG faculty member will also deliver a keynote speech to congress attendees.

The international event, which will be held at the Catholic University of Argentina in Buenos Aires, will feature acclaimed stem cell aesthetic practitioners from Argentina and the U.S. SOAME is a member of the Argentine Medical Association (A.M.A.) and of the International Union of Aesthetic Medicine (U.I.M.E.). SOAME has the scientific support of the John F. Kennedy University in Buenos Aires and a host of national and international scientific organizations.

For more information visit the Global Stem Cells Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.

About the Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

###

Related Organic Cosmetics Press Releases